FDA NDC Directory · JSON-LD · Markdown

Claritin Reditabs

NDC 11523-7202 · HUMAN OTC DRUG · TABLET, ORALLY DISINTEGRATING

Generic nameLoratadine
Labeler / ManufacturerBayer HealthCare LLC
Marketing categoryNew Drug Application (innovator) · App NDA021993
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsLORATADINE (5 mg/1)
Marketing started20061212
Package count2

External sources

Source: openFDA. Public-domain (CC0).